Lyndon F. Cooper

Lyndon F. Cooper

Auto-generated profile, based on publicly available information

Lyndon F. Cooper

School of Dentistry, Virginia Commonwealth University, Richmond, VA, USA

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in Biomaterials
Verified
Journal Article
Closed access
GMGustavo Mendonça
Gustavo Mendonça
DMDaniela B.S. Mendonça
Daniela B.S. Mendonça
FAFrancisco J.L. Aragão
Francisco J.L. Aragão
LCLyndon F. Cooper
Lyndon F. Cooper

1 January 2002 in Bone
Verified
Journal Article
Closed access
CCC.M. Champagne
C.M. Champagne
JTJ. Takebe
J. Takebe
SOS. Offenbacher
S. Offenbacher
LCL.F. Cooper
L.F. Cooper

1 February 2006 in Biomaterials
Verified
Journal Article
Closed access
LCLyndon F. Cooper
Lyndon F. Cooper
YZYongsheng Zhou
Yongsheng Zhou
JTJun Takebe
Jun Takebe
JGJuanli Guo
Juanli Guo
AAArmin Abron
Armin Abron
JEJan Eirik Ellingsen
Jan Eirik Ellingsen

1 March 2004 in Tissue Engineering
Verified
Journal Article
Closed access
KHKevin C. Hicok
Kevin C. Hicok
TLTracey V. du Laney
Tracey V. du Laney
YZYang Sheng Zhou
Yang Sheng Zhou
YHYuan-Di C. Halvorsen
Yuan-Di C. Halvorsen
DHDaron C. Hitt
Daron C. Hitt
JGJeffrey M. Gimble
Jeffrey M. Gimble
Adult subcutaneous fat tissue is an abundant source of multipotent cells. Previous studies from our laboratory have shown that, in vitro, adipose-derived adult stem (ADAS) cells express bone marker proteins including alkaline phosphatase, type I collagen, osteopontin, and osteocalcin and produce a mineralized matrix as shown by alizarin red staining. In the current study, the ADAS cell ability to form osteoid in vivo was determined. ADAS cells were isolated from liposuction waste of three individual donors and expanded in vitro before implantation. Equal numbers of cells (3 x 10(6)) were loaded onto either hydroxyapatite/tricalcium phosphate (HA-TCP) cubes or the collagen/HA-TCP composite matrix, Collagraft, and then implanted subcutaneously into SCID mice. After 6 weeks, implants were removed, fixed, and demineralized and sectioned for hematoxylin and eosin staining. Osteoid formation was observed in 80% of HA-TCP implants loaded with ADAS cells. Only 20% of Collagraft implants were positive for the presence of osteoid matrix. Whereas 100% of HA-TCP implants loaded with hFOB 1.19 cells formed osteoid, Collagraft loaded with hFOB 1.19 cells displayed a high degree of adipose tissue within the matrix. Immunostaining of serial sections for human nuclear antigen demonstrated that the osteoid contained human cells. Osteoid formation was not observed in control HA-TCP or Collagraft matrices implanted without cells. In summary, the data demonstrate the ability of ADAS cells to form osteoid matrix in vivo. Because of their abundance and accessibility, ADAS cells may prove to be a novel cell therapeutic for bone repair and regeneration.

1 November 2000 in The Journal of Prosthetic Dentistry
Verified
Journal Article
Closed access
LCLyndon F. Cooper
Lyndon F. Cooper

1 September 2009 in Biomaterials
Verified
Journal Article
Closed access
GMGustavo Mendonça
Gustavo Mendonça
DMDaniela B.S. Mendonça
Daniela B.S. Mendonça
LSLuis G.P. Simões
Luis G.P. Simões
AAAndré L. Araújo
André L. Araújo
ELEdson R. Leite
Edson R. Leite
LCLyndon F. Cooper
Lyndon F. Cooper